Bristol Myers Squibb (BMY) Operating Income (2009 - 2026)
Bristol Myers Squibb (BMY) reported Operating Income of -$182.0 million for Q1 2026, down 193.55% year-over-year from $194.6 million in Q1 2025, and up 93.07% on a QoQ basis from -$2.6 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Operating Income data on file, last reported at -$182.0 million in Q1 2026.
- Quarterly Operating Income fell 193.55% year-over-year to -$182.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.7 billion (up 40.6% YoY) and the FY2025 annual result came in at -$4.6 billion, up 79.38% from the prior year.
- Operating Income advanced to -$182.0 million in Q1 2026 per BMY's latest filing, from -$2.6 billion in the prior quarter.
- Across five years, Operating Income topped out at $204.0 million in Q1 2023 and bottomed at -$14.4 billion in Q1 2024.
- The 5-year median for Operating Income is -$784.0 million (2022), against an average of -$1.9 billion.
- The widest annual swing landed in 2023, when Operating Income soared 126.02%; it then sank 7182.35% in 2024.
- Tracing BMY's Operating Income over 5 years: stood at -$734.0 million in 2022, then plunged by 45.91% to -$1.1 billion in 2023, then tumbled by 332.96% to -$4.6 billion in 2024, then soared by 43.35% to -$2.6 billion in 2025, then surged by 93.07% to -$182.0 million in 2026.
- Per Business Quant, the three latest BMY Operating Income figures stand at -$182.0 million (Q1 2026), -$2.6 billion (Q4 2025), and -$321.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 9.50 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 6.36 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.99 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -7.73 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.67 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.59 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -6.71 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -182.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182.00 Mn |
| Dec 31, 2025 | -2.63 Bn |
| Sep 30, 2025 | -321.00 Mn |
| Jun 30, 2025 | -1.60 Bn |
| Mar 31, 2025 | -62.00 Mn |
| Dec 31, 2024 | -4.64 Bn |
| Sep 30, 2024 | -1.28 Bn |
| Jun 30, 2024 | -1.98 Bn |
| Mar 31, 2024 | -14.45 Bn |
| Dec 31, 2023 | -1.07 Bn |
| Sep 30, 2023 | -369.00 Mn |
| Jun 30, 2023 | -1.02 Bn |
| Mar 31, 2023 | 204.00 Mn |
| Dec 31, 2022 | -734.00 Mn |
| Sep 30, 2022 | -144.00 Mn |
| Jun 30, 2022 | -762.00 Mn |
| Mar 31, 2022 | -784.00 Mn |
| Dec 31, 2021 | -498.00 Mn |
| Sep 30, 2021 | -134.00 Mn |
| Jun 30, 2021 | -899.00 Mn |
| Mar 31, 2021 | -311.00 Mn |
| Dec 31, 2020 | -13.36 Bn |
| Sep 30, 2020 | -245.00 Mn |
| Jun 30, 2020 | -1.07 Bn |
| Mar 31, 2020 | -3.97 Bn |
| Dec 31, 2019 | -2.62 Bn |
| Sep 30, 2019 | -441.00 Mn |
| Jun 30, 2019 | -196.00 Mn |
| Mar 31, 2019 | 155.00 Mn |
| Dec 31, 2018 | -105.00 Mn |
| Sep 30, 2018 | 519.00 Mn |
| Jun 30, 2018 | -1.11 Bn |
| Mar 31, 2018 | 195.00 Mn |
| Dec 31, 2017 | -903.00 Mn |
| Sep 30, 2017 | -396.00 Mn |
| Jun 30, 2017 | -274.00 Mn |
| Mar 31, 2017 | 690.00 Mn |
| Dec 31, 2016 | -320.00 Mn |
| Sep 30, 2016 | 254.00 Mn |
| Jun 30, 2016 | 409.00 Mn |
| Mar 31, 2016 | 603.00 Mn |
| Dec 31, 2015 | -1.36 Bn |
| Sep 30, 2015 | -110.00 Mn |
| Jun 30, 2015 | -961.00 Mn |
| Mar 31, 2015 | 601.00 Mn |
| Dec 31, 2014 | -1.03 Bn |
| Sep 30, 2014 | 1.00 Mn |
| Jun 30, 2014 | -543.00 Mn |
| Mar 31, 2014 | 17.00 Mn |
| Dec 31, 2013 | -404.00 Mn |
| Sep 30, 2013 | -357.00 Mn |
| Jun 30, 2013 | -578.00 Mn |
| Mar 31, 2013 | -389.00 Mn |
| Dec 31, 2012 | -562.00 Mn |
| Sep 30, 2012 | -2.25 Bn |
| Jun 30, 2012 | -186.00 Mn |
| Mar 31, 2012 | 724.00 Mn |
| Dec 31, 2011 | 227.00 Mn |
| Sep 30, 2011 | 423.00 Mn |
| Jun 30, 2011 | 309.00 Mn |
| Mar 31, 2011 | 424.00 Mn |
| Dec 31, 2010 | -1.00 Mn |
| Sep 30, 2010 | 334.00 Mn |
| Jun 30, 2010 | 315.00 Mn |
| Mar 31, 2010 | 146.00 Mn |
| Dec 31, 2009 | -113.00 Mn |
| Sep 30, 2009 | 248.00 Mn |
| Jun 30, 2009 | 297.00 Mn |
| Mar 31, 2009 | 30.00 Mn |